Promoting the use of oral ondansetron in children receiving cancer chemotherapy.
Walker
P C
PC
College of Pharmacy, University of Michigan, Ann Arbor, USA.
Biglin
K E
KE
Constance
T D
TD
Bhambhani
K
K
Sims-McCallum
R
R
D000284:Administration, Oral; D000932:Antiemetics / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002648:Child; D002985:Clinical Protocols; D003363:Cost Control; D003365:Costs and Cost Analysis; D006801:Humans; D007275:Injections, Intravenous; D017294:Ondansetron / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced* / Q000191:economics / Q000517:prevention & control*
D000932:Antiemetics; D000970:Antineoplastic Agents; D017294:Ondansetron